Close
  Indian J Med Microbiol
 

Figure 6: Heterogeneity indicators for the outcome of “fistula improvement” in the studies considering short- and long-term induction of anti-tumor necrosis factor-alpha medicines comparing to placebo therapy in fistulizing Crohn's disease patients

Figure 6: Heterogeneity indicators for the outcome of “fistula improvement” in the studies considering short- and long-term induction of anti-tumor necrosis factor-alpha medicines comparing to placebo therapy in fistulizing Crohn's disease patients